EUDA Health Holdings repurchased and canceled a warrant from Streeterville Capital for $125,000, eliminating share issuance potential.
Quiver AI Summary
EUDA Health Holdings Limited, a Singapore-based non-invasive healthcare provider, announced the complete repurchase and cancellation of a warrant previously issued to Streeterville Capital, LLC for a total of $125,000. The warrant, which was associated with the purchase of up to 2,000,000 ordinary shares, was initially part of a securities purchase agreement from November 26, 2025, and had undergone amendments in December 2025 and January 2026. Following the cancellation, no warrants remain under this agreement, fully eliminating the potential issuance of related shares. EUDA aims to lead in non-invasive and preventive healthcare in Asia, targeting the growing longevity sector to meet the needs of a rapidly aging population.
Potential Positives
- The company successfully repurchased and cancelled the warrant issued to Streeterville Capital, effectively eliminating the potential dilution of shares associated with it.
- The repurchase of the warrant for US$125,000 indicates a proactive financial management strategy, showcasing the company's commitment to maintaining shareholder value.
- This transaction may enhance investor confidence as it removes uncertainty related to the potential issuance of new shares.
Potential Negatives
- The company repurchased and cancelled a warrant for US$125,000, indicating a potential need to reduce future dilution of shares, which could suggest financial strain or uncertainty in growth prospects.
- The fact that the warrant was amended multiple times prior to its cancellation may raise concerns about the initial terms and the company's ability to secure favorable financing arrangements.
- The cancellation of the warrant suggests that the company plans to avoid future obligations to issue shares, which could be interpreted as a sign of challenges in attracting or retaining investment confidence.
FAQ
What did EUDA Health Holdings Limited announce on March 4, 2026?
EUDA announced the repurchase and cancellation of a warrant issued to Streeterville Capital, LLC.
What was the total purchase price for the repurchased warrant?
The warrant was repurchased for a total price of US$125,000.
How many shares could the warrant have been converted into?
The warrant could have been converted into up to 2,000,000 newly issued ordinary shares of the Company.
What regions does EUDA Health Holdings focus on for its healthcare services?
EUDA focuses on Singapore, Malaysia, and China for its non-invasive healthcare services.
What is EUDA Health Holdings' mission in healthcare?
EUDA aims to transform healthcare from reactive treatment to proactive, longevity-focused care for over 1.8 billion people.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$EUDA Hedge Fund Activity
We have seen 2 institutional investors add shares of $EUDA stock to their portfolio, and 2 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HUDSON BAY CAPITAL MANAGEMENT LP removed 320,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $739,200
- CITADEL ADVISORS LLC removed 44,631 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $103,097
- JANE STREET GROUP, LLC added 25,675 shares (+inf%) to their portfolio in Q4 2025, for an estimated $59,309
- UBS GROUP AG added 676 shares (+1408.3%) to their portfolio in Q4 2025, for an estimated $1,561
- SBI SECURITIES CO., LTD. added 0 shares (+0.0%) to their portfolio in Q4 2025, for an estimated $0
- GEODE CAPITAL MANAGEMENT, LLC added 0 shares (+0.0%) to their portfolio in Q4 2025, for an estimated $0
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
SINGAPORE, March 04, 2026 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited (NASDAQ: EUDA) (“EUDA” or the “Company”), a Singapore based non-invasive healthcare provider in Asia focused on Singapore, Malaysia and China, today announced that it has repurchased and cancelled in full the warrant previously issued to Streeterville Capital, LLC.
Background of the Warrant
As previously disclosed, the Company entered into a securities purchase agreement dated November 26, 2025 with an accredited investor for the purchase of a warrant that was immediately exercisable into up to 2,000,000 newly issued ordinary shares of the Company. The warrant was previously amended on December 16, 2025 and January 13, 2026.
Repurchase and Cancellation
On February 27, 2026, the Company repurchased the warrant in full for a total purchase price of US$125,000. Following the repurchase, the warrant was cancelled and is no longer outstanding.
As a result of this transaction, there are no warrants remaining under this agreement, and the potential issuance of shares associated with the warrant has been fully eliminated.
About EUDA Health Holdings Limited
EUDA Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based leading non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China. The Company aims to become a market leader in non-invasive and preventive healthcare, with a strategic focus on the fast-growing longevity sector. Our mission is to address the evolving healthcare needs of over 1.8 billion people across the region which is experiencing significant demographic shifts as more than 30% of the population ages rapidly. By offering innovative, accessible, and science-backed health solutions, EUDA is positioned to lead the transformation of regional healthcare from reactive medical treatment to proactive, longevity-focused care. EUDA also runs a Singapore-based property management business.
Forward-Looking Statements
This document may contain forward-looking statements regarding risks and uncertainties. These statements usually use forward-looking words, such as the words “estimates,” “projected,” “expects,” “envisions,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions). These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside EUDA’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. You should not overly rely on forward-looking statements that are only applicable to the date of publication of this document. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Christensen Advisory
Christian Arnell
Phone: +852 2117 0861
Email:
[email protected]
